How international laws affect cannabis regulations: the
examples of Uruguay and Malta
Moderation: Stefan Martin Meyer (PhytoFlow GmbH)
Speaker: Alfredo Pascual (Seed Innovations) and Andrew Bonello (ReLeaf Malta)
150 episodes of The Cannabis Conversation podcast
Speaker: Anuj Desai (Canverse)
Trichomes of cannabis: their structure, function, and density
Speaker: Dr. Callie Seaman (Aqualabs)
Education: your key to market development
Speaker: Viola Brugnatelli (Cannabiscienza)
Safety and transparency in cannabis products
Speaker: Michela Mastropietro (Swiss Queen GmbH)
Project Manager & Product Owner
Cannavigia/ Vigia AG
As Project Manager and product owner at Cannavigia, Pia Meyer supports and coordinates pilot projects for the legalization of cannabis and is responsible for the further development of their software module for customer engagement and marketing.
Cannabis consultant for research and education
Legal Cannabis Coalition (LCC)
Dr. Arno Hazekamp became one of the first cannabis researchers in Europe when he started his PhD on medicinal cannabis in the Netherlands in 2003. As a biochemist, he has worked for Dutch LP Bedrocan, advised the Dutch Office of Medicinal Cannabis, and supported numerous cannabis projects around the world as an independent consultant.
Pure Holding AG
Lino Cereghetti studied Biology and Agricultural Sciences at ETH Zürich. He acquired important national and international business experience in the field of start-ups, development and consulting. As Chief Operating Officer at Pure Holding AG, he is responsible for the ongoing strategic and political development of the group. In August 2020, he was elected as a member of the Executive Board at the Swiss Cannabis Industry Association. Within Interest Group Hemp, he focuses on regulatory affairs.
Daniel Haymann heads the Cannabis department at MLL and advises investors and companies on the cannabis market in contract and company law as well as other regulatory issues.
Daniela E. Eigenmann lavora quale farmacista co-direttrice nel reparto cannabis della Bahnhof Apotheke di Langnau, la farmacia della stazione, il cui direttore è il dottor Manfred Fankhauser ed è una pioniera nel settore della canapa medicinale in Svizzera. Daniela E. Eigenmann è responsabile della produzione e della distribuzione di medicamenti a base di cannabis, nonché della consulenza e dell’assistenza alla clientela. Quale relatrice motivata si impegna nella tematica della cannabis e nelle relative applicazioni terapeutiche.
Federal Office for Public Health
Since September 2019, Christian Werz has been working as a research assistant at the Federal Office for Public Health in the field of Political Foundations and Enforcement. One of his primary tasks is the processing and evaluation of applications for the granting of therapeutic use exemptions in connection with cannabis and other prohibited narcotics. He originally studied biology and in 2004 completed a thesis in the field of molecular biology and genetics in Switzerland. In the meantime, he has become a German/Swiss dual national and lives in Zurich.
Mitbegründerin & Managing Director
Swiss Queen GmbH
Michela Mastropietro is a multilingual, young and driven entrepreneur with a dedicated work ethic and ability to implement and manage deliverables in a highly dynamic and complex industry. Michela has worked with leading organizations, acquiring in-depth training in the Swiss financial sector before having had the opportunity to collaborate with notable start-ups and develop scale-ups and strategic partnerships with big players and leading manufacturing companies globally in the up-and-coming cannabis industry. Michela’s mission is driven by the desire to share education and knowledge among industry participants and society in order to provide safe access to cannabis across the globe. “Together we grow.” – Michela Mastropietro
Dr. iur. Daniel Donauer
LL.M. (Health Law)
CAS (Medicine Law)
Daniel Donauer is a lawyer at the MLL law firm and specializes in health and medical law issues. In this context, he advises his clients, among other things, about Swiss product implementation (i.e. medicinal products, medications, food, cosmetics issues, other commodities, chemicals and alcohol and tobacco).
Founder and Chief Sales Officer
Hemp activist since 1999. 100% dedicated to hemp business since 2011. Co-founded CBDepot in 2014. Providing advisory to various trade associations.
A founding member and executive board member of the German professional body BvCW e.V. and an active member of the Cannafem Network – a professional network for women, hemp and cannabis.
Lisa Haag has been working in the cannabis industry since 2017. In July 2018, she founded MJ_UNIVERSE GmbH, a publisher for digital products (e.g. Krautinvest.de) and a collaborative network for connecting companies across the hemp and cannabis value chain. She collaborates with a network of specialist experts to provide companies with advice on how to navigate around the cannabis ecosystem in Europe. She has completed an apprenticeship in business administration (IUBH, Bad Honnef) and a Bachelor’s degree in Business (Victoria University, Melbourne) in Hospitality Management. Lisa has been working for many years at companies operating in strategic and regional sales for facility management services (IFM, TFM, CFM, etc.).
Franziska Katterbach is an accomplished business executive and legal expert (zugelassene Rechtsanwältin) who brings extensive experience working within Europe's emerging cannabis industry. After completing her legal studies at Universität Leipzig and Landgericht Darmstadt, Franziska joined the corporate law firm Dentons, where she was involved in high-profile deals in the cannabis sector across multiple jurisdictions. Franziska later served as Director of Legal for Canopy's European operations, before joining Khiron. With 8+ years of regulatory expertise and 4+ as business executive in the European emerging cannabis industry, Franziska has well rounded knowledge in the industry. Franziska is considered a pioneer of the medical cannabis market in Germany, working in the medical cannabis industry in Europe on executive level since the very beginning in 2016.
Lito Michael Schulte
Since 2020, Lito Michael Schulte has been advising large pharmacists, food business operators and distributors specializing in cannabis with economic law issues relating to the German-European regulatory framework. He is currently undertaking a Master’s degree in Commercial Law (LL.M.) at the University of Münster and is working towards a PhD on a topic relating to corporate law.
Stefan Martin Meyer, MBA, was raised in the Italian side of Switzerland, near the city of Lugano. He then moved to Spain where he co-founded Phytoplant Research SL, which was granted the first research license for medicinal cannabis in Spain in 2012. While there he was able to get various R&D grants by the European Union for projects related to cannabinoids and medicine as well as publish results in high impact scientific journals. In 2019 Stefan joined Plena Global Holding Inc (Canada) as Chief Strategy Officer, where he has been leading a project licensed to grow medicinal cannabis in Colombia. In 2020 Stefan founded Phytoflow GmbH, a Swiss based company providing experience-driven strategic business advice to companies active in the medical cannabis sector.
VP of Investment Analysis
Seed Innovations (LON: SEED)
Based in Germany, Alfredo is a prominent cannabis industry analyst who has been identifying opportunities and generating unique insights for businesses and investors in Europe and Latin America since 2016. He is currently VP of Investment Analysis of Seed Innovations Ltd (LON: SEED), the AIM quoted company investing in fast growing and industry leading businesses with a focus on the medical cannabis, health and wellness space. Before joining Seed Innovations, Alfredo worked as International Analyst at MJBiz, the leading US-based B2B resource for the cannabis industry, where he focused on covering how markets and investments were evolving internationally. Alfredo has a Bachelor of Business Administration and a Master of Governance and Public Policy.
Andrew Bonello is the President of ReLeaf Malta and has since 2019, has worked tirelessly to represent the voice of cannabis consumers in Malta. Andrew actively meets various local players and international experts to discuss issues related to cannabis, human rights and public health, more specifically advocating for a more just, humane and non-criminal approach. Today, Andrew remains committed to pushing for a truly decriminalized and regulated approach to cannabis, placing the well-being of consumers at the heart of every decision.
Anuj Desai is host of Europe’s leading cannabis industry podcast, The Cannabis Conversation, having interviewed over 150 global cannabis thought leaders. He is a qualified lawyer, having worked in a variety of senior roles in the UK media industry over 15 years and now acts as a legal consultant and board advisor to cannabis start-ups and SMEs in the UK. Anuj has developed and continues to expand an extensive global network in the cannabis, CBD, cannabinoid and hemp sectors.
Dr. Callie Seaman (PhD)
Callie Seaman PhD is a veteran of the hydroponics industry with over 20 years’ experience in cannabis cultivation and research. She is a medical cannabis patient who strives to educate people about epilepsy and the benefits of medicinal cannabis.
Viola started working as a neuropharmacologist within the cannabis field in 2012, investigating novel cannabinoid receptors at the Ninewells Hospital, NHS, (Scotland). Since 2017 she is a lecturer on endocannabinology and medical cannabis and researcher at the Department of Neuroscience, University of Padua (Italy). In 2018 she co-founded Cannabiscienza Srl, a science company dedicated to educate Italy's next generation of medical cannabis leaders. In 2022 Viola co-founded Cannabiscientia SA (Switzerland) to extend this mission worldwide.
Register now and get access to the data of all participating companies.
|Adec Solutions GmbH||CH||Harvesting equipment|
|Airnatech Antiviral SL||ES||NONE|
|Alfredo Dupetit||UY||Seeds, Plants, Genetics|
|Appleton Luff International Lawyers||CH||NONE|
|Artemis Growth Partners||US||NONE|
|Asahi Glassplant UK Ltd (AGI UK||GB||NONE|
|Bahnhof Apotheke Langnau AG||CH||NONE|
|BioPower GmbH||CH||Seeds, Plants, Genetics|
|Bryan Garnier & Co||DE||NONE|
|Bundesamt für Gesundheit||CH||Institute|
|Calyx Grow (Pty) Ltd||ZA||NONE|
|Canna Switzerland GmbH||CH||Grow material|
|CanniFex by Pinho Santos||CH||NONE|
|CarbonActive GmbH||CH||Room Technology|
|CB Company Switzerland||CH||NONE|
|CDC LAB SA||CH||NONE|
|Dovetail Consulting S.L.||ES||NONE|
|eight Industries GmbH||CH||NONE|
|Essence Vert GmbH||CH||CBD|
|FAZZ Global SA||CH||NONE|
|gempex GmbH, NL Schweiz||CH||NONE|
|GIZEH Raucherbedarf GmbH||DE||Paraphernalia|
|GNB SWISS INVESTMENTS AG||CH||NONE|
|Good Rechtsanwälte GmbH||CH||NONE|
|Green Agrotrade AG||CH||NONE|
|GrowMax Water Europe SL||ES||NONE|
|Guttentag Solutions GmbH (CBD-Test)||CH||Laboratory / Equipment|
|Harbour 22 GmbH||CH||NONE|
|IG Hanf - CI Chanvre - CI Canapa||CH||Institute|
|International Extraction Services||GR||NONE|
|J. Willers Engineering AG||CH||NONE|
|JKB Research SA||CH||CBD|
|Khiron Europe GmbH||DE||NONE|
|Kiara naturals AG||CH||Medicine|
|Koppert Deutschland GmbH||DE||NONE|
|Kygron Deutschland GmbH||DE||NONE|
|la abeja inversiones agrarias||ES||NONE|
|Legal Cannabis Coalition||NL||NONE|
|Lumino Group Limited||GB||NONE|
|MediCrops Holding AG||CH||NONE|
|Members Only GmbH||CH||NONE|
|MJ Universe GmbH||DE||Services|
|MLL Meyerlustenberger Lachenal Froriep AG||CH||Legal consulting|
|Neuraxpharm Switzerland AG||CH||NONE|
|Olla Botanicals Ltd.||CH||CBD|
|Philip Morris Products SA||CH||NONE|
|Phytoflow GmbH||CH||Legal consulting|
|Pure Holding AG||CH||CBD|
|Sainfort Production AG||CH||NONE|
|Schibano Pharma Group||CH||NONE|
|Seed Innovations (LON: SEED)||GG||NONE|
|Slow Farm SA||CH||NONE|
|Spaceafrica GmbH / Invegrow||CH||NONE|
|Stecklingsfarm.ch GmbH||CH||Seeds, Plants, Genetics|
|Swiss Alpinopharma GmbH||DE||NONE|
|Swiss Business Hub Southern Africa||ZA||NONE|
|Swiss Hemp Lab AG||CH||NONE|
|Swiss Organic Partners AG||CH||CBD|
|Swiss Quality Hemp GmbH||CH||NONE|
|Swiss Queen GmbH||CH||CBD|
|Swiss Society for Cannabis in Medicine, SGCM-SSCM||CH||Medicine|
|uWeed by Digital Hive GmbH||CH||CBD|
|Vigia AG / Cannavigia||CH||Logistics|
Register now and get access to the data of all participating companies.
The world of events has become uncertain since the outbreak of the Covid pandemic in spring 2020. The following rules apply to the CB Club in relation to the Covid situation and other epidemics/pandemics:
The CB Company is taking the Covid situation very seriously and is planning the CB Club 2022 in close collaboration with the relevant responsible authorities. A limited number of people inside, sanitizer dispensers at all the key points and mandatory mask wearing and testing, depending on the situation.
The CB Club will take place if allowed by the legally applicable measures governing events in Switzerland at that time and taking into account the international travel situation.
Cancellation / Postponement
If the CB Club has to be cancelled due to Covid, a replacement date will be announced. Any tickets already purchased will be valid on the new date or else a refund can be issued free-of-charge within 10 days of the announcement.
Quarantine / Travel Bans
If travel is not possible due to quarantine regulations or travel bans, we request that customers contact us as soon as possible to find a solution.
In the event of illness, visitors have the option to transfer their tickets to other individuals from their company. A refund cannot be guaranteed in this case.